Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Comments for:

What’s in a name? eNOS and anaphylactic shock
Charles J. Lowenstein, Thomas Michel
Charles J. Lowenstein, Thomas Michel
Published August 1, 2006
Citation Information: J Clin Invest. 2006;116(8):2075-2078. https://doi.org/10.1172/JCI29406.
View: Text | PDF
Commentary

What’s in a name? eNOS and anaphylactic shock

  • Text
  • PDF
Abstract

In this issue of the JCI, a study by Cauwels and colleagues suggests a central role for eNOS, the endothelial isoform of nitric oxide synthase, as a mediator of anaphylaxis (see the related article beginning on page 2244). Why is an enzyme originally described as a physiological mediator of vascular homeostasis implicated in the spectacular vascular collapse that is characteristic of anaphylaxis? And is the eNOS involved in anaphylaxis necessarily exerting its effect solely in the vascular endothelium, or might this “endothelial enzyme” actually be playing a more fundamental role in an entirely different tissue? After all, what’s in a name?

Authors

Charles J. Lowenstein, Thomas Michel

×

Nitric oxide in human anaphylaxis

Submitter: Giovanni Rolla | grolla@mauriziano.it

Allergy and Clinical Immunology - University of Torino - ASO Ordine Mauriziano Umberto I - Torino

Published August 16, 2006

Charles J. Lowenstein and Thomas Michel wonder, in their commentary to the Cauwels’ article, whether NO mediates hypotension following anaphylaxis in humans as well. Very recently we measured high level of exhaled NO during anaphylaxis induced by specific bee-venom immunotherapy in a bee-keeper (1). The other common causes of increased exhaled NO, including asthma, allergic rhinitis or recent respiratory tract infection (2) were excluded. We suggest that the increased production of NO by respiratory tract in anaphylaxis mirrors increase in NO production by systemic circulatory system, as suggested by the relationship between exhaled NO and dialysis-induced hypotension (3). Our observation lends support to the hypothesis that NO plays an important role in human anaphylaxis and that NO-inhibiting drugs could theoretically be useful in the most severe cases refractory to epinephrine treatment (4)

1 – Rolla G, Nebiolo F, Guida G, Heffler E, Bommarito L, Bergia R. Increased exhaled nitric oxide during human anaphylaxis. Ann Allergy Asthma Immunol 2006; 97: 264-5.
2 – Ricciardolo FL, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004; 84: 731-765.
3 – Raj DS, Vincent B, Simpson K, Sato E, Jones KL, Welbourne TC et al. Hemodynamic changes during hemodialysis : role of nitric oxide and endothelin. Kidney Int 2002; 61: 697-704.
4 – Oliveira Neto AM, Duarte NM, Vicente WV, Viaro F, Evora PR. Methylene blue: an effective treatment for contrast medium-induced anaphylaxis. Med Sci Monit 2003; 9: CS102-CS106.

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts